Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

BACKGROUND: A British randomised study of gemcitabine plus cisplatin (GC) combination showed promising results in biliary tract cancer (BTC) patients. In our study, we evaluated the efficacy and safety of this combination compared with gemcitabine alone (G) in Japanese BTC patients. METHODS: Overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Okusaka, T, Nakachi, K, Fukutomi, A, Mizuno, N, Ohkawa, S, Funakoshi, A, Nagino, M, Kondo, S, Nagaoka, S, Funai, J, Koshiji, M, Nambu, Y, Furuse, J, Miyazaki, M, Nimura, Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939781/
https://www.ncbi.nlm.nih.gov/pubmed/20628385
http://dx.doi.org/10.1038/sj.bjc.6605779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939781/
https://www.ncbi.nlm.nih.gov/pubmed/20628385
http://dx.doi.org/10.1038/sj.bjc.6605779

Ejemplares similares